Vitality Watch

Dossier pubmed review 13-jun-2026
Narrative review or expert overview without new data

Frailty and heart failure: Clinical impact, biomarkers, and phenotypic differences.

Key claim: Frailty is highly prevalent in heart failure, independently predicts hospitalization, mortality, and worse quality of life, and differs across HFrEF, HFpEF, and HFmrEF in ways that call for phenotype-specific assessment and management.

Abstract

Frailty is a multidimensional geriatric syndrome characterized by reduced physiologic reserve and increased vulnerability to stressors. Its prevalence is particularly high among patients with heart failure (HF), reflecting the interplay between aging, multimorbidity, and chronic cardiovascular disease. Frailty independently predicts poor outcomes, including higher hospitalization rates, mortality, and impaired quality of life. The Fried Frailty Phenotype defines frailty as the presence of three or more of the following five criteria: unintentional weight loss, exhaustion, weakness (grip strength), slow walking speed, and low physical activity. In this review, we explore the complex relationship between frailty and HF, with a focus on pathophysiology, clinical outcomes, biomarkers, and therapeutic considerations. We highlight differences across HF phenotypes-heart failure with reduced ejection fraction (HFrEF), preserved ejection fraction (HFpEF), and mildly reduced ejection fraction (HFmrEF)-underscoring the importance of tailored, phenotype-specific approaches. We also discuss emerging biomarkers including the stress hyperglycemia ratio (SHR) in HFpEF. Finally, we address limitations of current evidence and future directions for integrating frailty assessment into HF management.

Why this matters

Frailty is highly prevalent in heart failure, independently predicts hospitalization, mortality, and worse quality of life, and differs across HFrEF, HFpEF, and HFmrEF in ways that call for phenotype-specific assessment and management.

Source

Link

Briefing card

Frailty and heart failure: Clinical impact, biomarkers, and phenotypic differences.
Stage: review · pubmed · 13-jun-2026

Frailty is highly prevalent in heart failure, independently predicts hospitalization, mortality, and worse quality of life, and differs across HFrEF, HFpEF, and HFmrEF in ways that call for phenotype-specific assessment and management.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.amjms.2026.06.013

build build 880 · 2bcef25 · 2026-11-18